Clinical Trial Update: Adjuvant Aspirin Treatment for Colon Cancer Patients [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating adjuvant aspirin in colon cancer has been terminated; results have been posted on 2025-05-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Colon Cancer | Phase 3 | Status: TERMINATED | Results posted: 2025-05-16